keyword
https://read.qxmd.com/read/38605232/dysregulations-of-amino-acid-metabolism-and-lipid-metabolism-in-urine-of-children-and-adolescents-with-major-depressive-disorder-a-case-control-study
#1
JOURNAL ARTICLE
Yuanliang Jiang, Yuping Cai, Teng Teng, Xiaolin Wang, Bangmin Yin, Xuemei Li, Ying Yu, Xueer Liu, Jie Wang, Hongyan Wu, Yuqian He, Zheng-Jiang Zhu, Xinyu Zhou
RATIONALE: The mechanisms underlying major depressive disorder (MDD) in children and adolescents are unclear. Metabolomics has been utilized to capture metabolic signatures of various psychiatric disorders; however, urinary metabolic profile of MDD in children and adolescents has not been studied. OBJECTIVES: We analyzed urinary metabolites in children and adolescents with MDD to identify potential biomarkers and metabolic signatures. METHODS: Here, liquid chromatography-mass spectrometry was used to profile metabolites in urine samples from 192 subjects, comprising 80 individuals with antidepressant-naïve MDD (AN-MDD), 37 with antidepressant-treated MDD (AT-MDD) and 75 healthy controls (HC)...
April 12, 2024: Psychopharmacology
https://read.qxmd.com/read/38548210/evaluation-of-metabolomics-based-urinary-biomarker-models-for-recognizing-major-depression-disorder-and-bipolar-disorder
#2
JOURNAL ARTICLE
Tianjiao Wang, Jingzhi Yang, Yuncheng Zhu, Na Niu, Binbin Ding, Ping Wang, Hongxia Zhao, Na Li, Yufan Chao, Songyan Gao, Xin Dong, Zuowei Wang
BACKGROUND: Major depressive disorder (MDD) and bipolar disorder (BD) are psychiatric disorders with overlapping symptoms, leading to high rates of misdiagnosis due to the lack of biomarkers for differentiation. This study aimed to identify metabolic biomarkers in urine samples for diagnosing MDD and BD, as well as to establish unbiased differential diagnostic models. METHODS: We utilized a metabolomics approach employing ultra-high performance liquid chromatography-mass spectrometry (UHPLC-MS) to analyze the metabolic profiles of urine samples from individuals with MDD (n = 50), BD (n = 12), and healthy controls (n = 50)...
March 26, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38531835/identifying-plasma-metabolic-characteristics-of-major-depressive-disorder-bipolar-disorder-and-schizophrenia-in-adolescents
#3
JOURNAL ARTICLE
Bangmin Yin, Yuping Cai, Teng Teng, Xiaolin Wang, Xueer Liu, Xuemei Li, Jie Wang, Hongyan Wu, Yuqian He, Fandong Ren, Tianzhang Kou, Zheng-Jiang Zhu, Xinyu Zhou
Major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SCZ) are classified as major mental disorders and together account for the second-highest global disease burden, and half of these patients experience symptom onset in adolescence. Several studies have reported both similar and unique features regarding the risk factors and clinical symptoms of these three disorders. However, it is still unclear whether these disorders have similar or unique metabolic characteristics in adolescents. We conducted a metabolomics analysis of plasma samples from adolescent healthy controls (HCs) and patients with MDD, BD, and SCZ...
March 26, 2024: Translational Psychiatry
https://read.qxmd.com/read/38495098/anti-neuroinflammatory-effect-of-hydroxytyrosol-a-potential-strategy-for-anti-depressant-development
#4
JOURNAL ARTICLE
Shuaiguang Li, Huarong Shao, Ting Sun, Xinyan Guo, Xiaoyuan Zhang, Qingkai Zeng, Shaoying Fang, Xiaoyu Liu, Fan Wang, Fei Liu, Peixue Ling
Introduction: Depression is a complex psychiatric disorder with substantial societal impact. While current antidepressants offer moderate efficacy, their adverse effects and limited understanding of depression's pathophysiology hinder the development of more effective treatments. Amidst this complexity, the role of neuroinflammation, a recognized but poorly understood associate of depression, has gained increasing attention. This study investigates hydroxytyrosol (HT), an olive-derived phenolic antioxidant, for its antidepressant and anti-neuroinflammatory properties based on mitochondrial protection...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38424029/maximizing-analytical-performance-in-biomolecular-discovery-with-lc-ms-focus-on-psychiatric-disorders
#5
REVIEW
Bradley J Smith, Paul C Guest, Daniel Martins-de-Souza
In this review, we discuss the cutting-edge developments in mass spectrometry proteomics and metabolomics that have brought improvements for the identification of new disease-based biomarkers. A special focus is placed on psychiatric disorders, for example, schizophrenia, because they are considered to be not a single disease entity but rather a spectrum of disorders with many overlapping symptoms. This review includes descriptions of various types of commonly used mass spectrometry platforms for biomarker research, as well as complementary techniques to maximize data coverage, reduce sample heterogeneity, and work around potentially confounding factors...
February 29, 2024: Annual Review of Analytical Chemistry
https://read.qxmd.com/read/38418685/untargeted-metabolomic-and-proteomic-analysis-identifies-metabolic-biomarkers-and-pathway-alterations-in-individuals-with-22q11-2-deletion-syndrome
#6
JOURNAL ARTICLE
Marwa Zafarullah, Kathleen Angkustsiri, Austin Quach, Seungjun Yeo, Blythe P Durbin-Johnson, Heather Bowling, Flora Tassone
INTRODUCTION: The chromosome 22q11.2 deletion syndrome (22q11.2DS) is characterized by a well-defined microdeletion and is associated with a wide range of brain-related phenotypes including schizophrenia spectrum disorders (SCZ), autism spectrum disorders (ASD), anxiety disorders and attention deficit disorders (ADHD). The typically deleted region in 22q11.2DS contains multiple genes which haploinsufficiency has the potential of altering the protein and the metabolic profiles. OBJECTIVES: Alteration in metabolic processes and downstream protein pathways during the early brain development may help to explain the increased prevalence of the observed neurodevelopmental phenotypes in 22q11...
February 28, 2024: Metabolomics: Official Journal of the Metabolomic Society
https://read.qxmd.com/read/38401803/a-metabolome-wide-mendelian-randomization-study-identifies-dysregulated-arachidonic-acid-synthesis-as-a-potential-causal-risk-factor-for-bipolar-disorder
#7
JOURNAL ARTICLE
David Stacey, Beben Benyamin, S Hong Lee, Elina Hyppönen
BACKGROUND: Bipolar disorder (BPD) is a debilitating mood disorder with an unclear aetiology. A better understanding of the underlying pathophysiological mechanisms will help to identify novel targets for improved treatment options and prevention strategies. In this metabolome-wide Mendelian randomization study, we screened for metabolites that may have a causal role in BPD. METHODS: We tested a total of 913 circulating metabolite exposures assessed in 14,296 Europeans using a mass spectrometry-based platform...
February 22, 2024: Biological Psychiatry
https://read.qxmd.com/read/38392971/lipids-in-psychiatric-disorders-functional-and-potential-diagnostic-role-as-blood-biomarkers
#8
REVIEW
Yana Zorkina, Valeria Ushakova, Aleksandra Ochneva, Anna Tsurina, Olga Abramova, Valeria Savenkova, Anna Goncharova, Irina Alekseenko, Irina Morozova, Daria Riabinina, Georgy Kostyuk, Anna Morozova
Lipids are a crucial component of the human brain, serving important structural and functional roles. They are involved in cell function, myelination of neuronal projections, neurotransmission, neural plasticity, energy metabolism, and neuroinflammation. Despite their significance, the role of lipids in the development of mental disorders has not been well understood. This review focused on the potential use of lipids as blood biomarkers for common mental illnesses, such as major depressive disorder, anxiety disorders, bipolar disorder, and schizophrenia...
January 23, 2024: Metabolites
https://read.qxmd.com/read/38378926/effect-of-chemically-synthesized-psilocybin-and-psychedelic-mushroom-extract-on-molecular-and-metabolic-profiles-in-mouse-brain
#9
JOURNAL ARTICLE
Orr Shahar, Alexander Botvinnik, Amit Shwartz, Elad Lerer, Peretz Golding, Alex Buko, Ethan Hamid, Dani Kahn, Miles Guralnick, Karin Blakolmer, Gilly Wolf, Amit Lotan, Leonard Lerer, Bernard Lerer, Tzuri Lifschytz
Psilocybin, a naturally occurring, tryptamine alkaloid prodrug, is currently being investigated for the treatment of a range of psychiatric disorders. Preclinical reports suggest that the biological effects of psilocybin-containing mushroom extract or "full spectrum" (psychedelic) mushroom extract (PME), may differ from those of chemically synthesized psilocybin (PSIL). We compared the effects of PME to those of PSIL on the head twitch response (HTR), neuroplasticity-related synaptic proteins and frontal cortex metabolomic profiles in male C57Bl/6j mice...
February 20, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38340697/cerebrospinal-fluid-proteomic-signatures-are-associated-with-symptom-severity-of-first-episode-psychosis
#10
JOURNAL ARTICLE
Humza Haroon, Ada Man-Choi Ho, Vinod K Gupta, Surendra Dasari, Carl M Sellgren, Simon Cervenka, Göran Engberg, Feride Eren, Sophie Erhardt, Jaeyun Sung, Doo-Sup Choi
Apart from their diagnostic, monitoring, or prognostic utility in clinical settings, molecular biomarkers may be instrumental in understanding the pathophysiology of psychiatric disorders, including schizophrenia. Using untargeted metabolomics, we recently identified eight cerebrospinal fluid (CSF) metabolites unique to first-episode psychosis (FEP) subjects compared to healthy controls (HC). In this study, we sought to investigate the CSF proteomic signatures associated with FEP. We employed 16-plex tandem mass tag (TMT) mass spectrometry (MS) to examine the relative protein abundance in CSF samples of 15 individuals diagnosed with FEP and 15 age-and-sex-matched healthy controls (HC)...
February 2, 2024: Journal of Psychiatric Research
https://read.qxmd.com/read/38273106/human-microbiota-from-drug-naive-patients-with-obsessive-compulsive-disorder-drives-behavioral-symptoms-and-neuroinflammation-via-succinic-acid-in-mice
#11
JOURNAL ARTICLE
Ying-Dan Zhang, Dong-Dong Shi, Bing-Bing Liao, Yi Li, Sen Zhang, Jian Gao, Liang-Jun Lin, Zhen Wang
Emerging evidence suggests that the gut microbiota is closely related to psychiatric disorders. However, little is known about the role of the gut microbiota in the development of obsessive-compulsive disorder (OCD). Here, to investigate the contribution of gut microbiota to the pathogenesis of OCD, we transplanted fecal microbiota from first-episode, drug-naive OCD patients or demographically matched healthy individuals into antibiotic-treated specific pathogen-free (SPF) mice and showed that colonization with OCD microbiota is sufficient to induce core behavioral deficits, including abnormal anxiety-like and compulsive-like behaviors...
January 25, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38248841/disorders-of-copper-metabolism-in-children-a-problem-too-rarely-recognized
#12
REVIEW
Sabina Więcek, Justyna Paprocka
Copper plays an important role in metabolic processes. Both deficiency and excess of this element have a negative effect and lead to pathological conditions. Copper is a cofactor of many enzymatic reactions. Its concentration depends on the delivery in the diet, the absorption in enterocytes, transport with the participation of ATP7A/ATP7B protein, and proper excretion. Copper homeostasis disorders lead to serious medical conditions such as Menkes disease (MD) and Wilson's disease (WD). A mutation in the ATP7A gene is the cause of Menkes disease, it prevents the supply of copper ions to enzymes dependent on them, such as dopamine β-hydroxylase and lysyl oxidase...
January 7, 2024: Metabolites
https://read.qxmd.com/read/38224462/-streptococcus-salivarius-subsp-thermophilus-ccfm1312-enhanced-mice-resilience-to-activity-based-anorexia
#13
JOURNAL ARTICLE
Ran Zhu, Yuming Lan, Xin Qian, Jianxin Zhao, Gang Wang, Peijun Tian, Wei Chen
Probiotic intervention, already showing promise in the treatment of various psychiatric disorders like depression, emerges as a potential therapy for anorexia nervosa (AN) with minimal side effects. In this study, we established an activity-based anorexia (ABA) model to probe the pathogenesis of AN and assess the impact of probiotics on ABA mice. ABA resulted in a compensatory increase in duodenal ghrelin levels, impairing the regulation of feeding and the brain reward system. Intervention with Streptococcus salivarius subsp...
January 15, 2024: Food & Function
https://read.qxmd.com/read/38218254/biomarkers-of-bipolar-disorder-based-on-metabolomics-a-systematic-review
#14
REVIEW
Jin Chen, Nousayhah Amdanee, Xiaowei Zuo, Yu Wang, Muxin Gong, Yujing Yang, Hao Li, Xiangrong Zhang, Caiyi Zhang
Bipolar disorder (BD) is a severe affective disorder characterized by recurrent episodes of depression or mania/hypomania, which significantly impair cognitive function, life skills, and social abilities of patients. There is little understanding of the neurobiological mechanisms of BD. The diagnosis of BD is primarily based on clinical assessment and psychiatric examination, highlighting the urgent need for objective markers to facilitate the diagnosis of BD. Metabolomics can be used as a diagnostic tool for disease identification and evaluation...
January 11, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38198856/depicting-the-molecular-features-of-suicidal-behavior-a-review-from-an-omics-perspective
#15
REVIEW
Caibe Alves Pereira, Guilherme Reis-de-Oliveira, Bruna Caroline Pierone, Daniel Martins-de-Souza, Manuella Pinto Kaster
Background Suicide is one of the leading global causes of death. Behavior patterns from suicide ideation to completion are complex, involving multiple risk factors. Advances in technologies and large-scale bioinformatic tools are changing how we approach biomedical problems. The "omics" field may provide new knowledge about suicidal behavior to improve identification of relevant biological pathways associated with suicidal behavior. Methods We reviewed transcriptomic, proteomic, and metabolomic studies conducted in blood and post-mortem brains from individuals who experienced suicide or suicidal behavior...
December 21, 2023: Psychiatry Research
https://read.qxmd.com/read/38117827/the-relationship-between-sleep-gut-microbiota-and-metabolome-in-patients-with-depression-and-anxiety-a-secondary-analysis-of-the-observational-study
#16
JOURNAL ARTICLE
Arisa Tanaka, Kenji Sanada, Katsuma Miyaho, Tomoyuki Tachibana, Shunya Kurokawa, Chiharu Ishii, Yoshihiro Noda, Shinichiro Nakajima, Shinji Fukuda, Masaru Mimura, Taishiro Kishimoto, Akira Iwanami
BACKGROUND: Growing attention is paid to the association between alterations in the gut microbiota and their metabolites in patients with psychiatric disorders. Our study aimed to determine how gut microbiota and metabolomes are related to the sleep quality among patients with depression and anxiety disorders by analyzing the datasets of our previous study. METHODS: Samples were collected from 40 patients (depression: 32 patients [80.0%]); anxiety disorders: 8 patients [20...
2023: PloS One
https://read.qxmd.com/read/38112949/metabolomic-profiling-of-amino-acid-alterations-in-anorexia-nervosa-implications-for-appetite-regulation-and-therapeutic-strategies
#17
JOURNAL ARTICLE
K Donato, K Dhuli, A Macchia, M C Medori, C Micheletti, G Bonetti, M R Ceccarini, T Beccari, P Chiurazzi, S Cristoni, V Benfatti, L Dalla Ragione, M Bertelli
OBJECTIVE: Anorexia nervosa (AN), a severe psychiatric disorder primarily affecting adolescents and young adults, is characterized by extreme dietary restriction and distorted body image. While the psychological aspects of AN are well-documented, its intricate metabolic underpinnings remain less explored. We think that metabolomic analysis of hair samples emerges as a promising tool to unveil the complex physiological alterations in AN. This study aims to comprehensively profile amino acid concentrations in hair samples from AN patients and healthy controls...
December 2023: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38050025/health-supervision-for-children-and-adolescents-with-16p11-2-deletion-syndrome
#18
JOURNAL ARTICLE
Wendy K Chung, Faranak F Herrera
This clinical review is designed to assist the pediatrician, family physician or internist in caring for the child, adolescent, adult and family in whom a diagnosis of 16p11.2 deletion syndrome has been confirmed by chromosome analysis. Although a pediatrician's initial contact with the child is usually within the first 5 years of life, occasionally an adolescent or adult will be tested and diagnosed after their sibling or child has been diagnosed with the same condition. Age specific guidance for the clinician is provided in Supplement Fig 1...
December 1, 2023: Cold Spring Harbor Molecular Case Studies
https://read.qxmd.com/read/38010856/-corydalis-yanhusuo-polysaccharides-ameliorate-chronic-stress-induced-depression-in-mice-through-gut-microbiota-derived-short-chain-fatty-acid-activation-of-5-hydroxytryptamine-signaling
#19
JOURNAL ARTICLE
Yu Fang, Yanqing Li, Xin Liao, Jie Deng, Qiannan Wang, Jingtao Liang, Bohua Yan
Depression, a prevalent psychiatric disorder, presents a serious health risk to humans. Increasing evidence suggested that the gut microbiota and the 5-hydroxytryptamine (5-HT) pathway both contribute significantly to depression. This research aimed to investigate how Corydalis yanhusuo polysaccharides (CYP) could potentially alleviate depression induced by chronic unpredictable mild stress in mice, as well as its underlying mechanism. The sucrose preference test, tail suspension test, and forced swimming test were employed to evaluate the behavior of mice...
November 21, 2023: Journal of Medicinal Food
https://read.qxmd.com/read/38006718/metabolome-subtyping-reveals-multi-omics-characteristics-and-biological-heterogeneity-in-major-psychiatric-disorders
#20
JOURNAL ARTICLE
Meng Hao, Yue Qin, Yi Li, Yanqing Tang, Zehan Ma, Jingze Tan, Li Jin, Fei Wang, Xiaohong Gong
Growing evidence suggests that major psychiatric disorders (MPDs) share common etiologies and pathological processes. However, the diagnosis is currently based on descriptive symptoms, which ignores the underlying pathogenesis and hinders the development of clinical treatments. This highlights the urgency of characterizing molecular biomarkers and establishing objective diagnoses of MPDs. Here, we collected untargeted metabolomics, proteomics and DNA methylation data of 327 patients with MPDs, 131 individuals with genetic high risk and 146 healthy controls to explore the multi-omics characteristics of MPDs...
November 13, 2023: Psychiatry Research
keyword
keyword
76187
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.